Regenerative biomaterials and bioimplants processed from human amniotic membrane, with application in the wound care, surgical, sports medicine, ophthalmic and dental markets
Start Trial Get Full Profile
There’s no risk. Start your trial today to see profiles of MiMedx Group (OTCBB: MDXG; NASDAQ: MDXG) plus 4808 other startups.